Indiana University School of Medicine Peds/Psych/Child-Adolescent Psych

Topics

• Bipolar Disorder and Treatment 236
• Traumatic Brain Injury Research 233
• Schizophrenia research and treatment 211
• Substance Abuse Treatment and Outcomes 76
• Epilepsy research and treatment 72
• Attention Deficit Hyperactivity Disorder 51
• Child and Adolescent Psychosocial and Emotional Development 45
• Intensive Care Unit Cognitive Disorders 41
• Autism Spectrum Disorder Research 39
• Functional Brain Connectivity Studies 35
• Neurotransmitter Receptor Influence on Behavior 26
• Dementia and Cognitive Impairment Research 24

Most cited

1. Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.

   Lancet (London, England) · 2024 · 194 citations · Alan Breier

2. Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial.

   JAMA psychiatry · 2024 · 149 citations · Alan Breier

3. Functional Outcomes Over the First Year After Moderate to Severe Traumatic Brain Injury in the Prospective, Longitudinal TRACK-TBI Study.

   JAMA neurology · 2021 · 308 citations · Thomas McAllister

4. Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years.

   Human brain mapping · 2022 · 243 citations · Alan Breier

5. Increased mood disorder symptoms, perceived stress, and alcohol use among college students during the COVID-19 pandemic.

   Psychiatry research · 2021 · 237 citations · Stephanie Strong

6. Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia.

   The New England journal of medicine · 2021 · 278 citations · Alan Breier